{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T19:48:48Z","timestamp":1674848928127},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/j.bbrc.2004.08.135","type":"journal-article","created":{"date-parts":[[2004,9,14]],"date-time":"2004-09-14T17:15:35Z","timestamp":1095182135000},"page":"660-667","source":"Crossref","is-referenced-by-count":11,"title":["Telomerase inhibition is a specific early event in salvicine-treated human lung adenocarcinoma A549 cells"],"prefix":"10.1016","volume":"323","author":[{"given":"Wei-Jun","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Fei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze-Hong","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2004.08.135_bib1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0165-6147(03)00165-2","article-title":"Telomerase inhibition and telomere erosion: a two-pronged strategy in cancer therapy","volume":"24","author":"Odago","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbrc.2004.08.135_bib2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0304-3835(02)00708-5","article-title":"Telomerase inhibition as cancer therapy","volume":"194","author":"Saretzki","year":"2003","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2004.08.135_bib3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1128\/MMBR.66.3.407-425.2002","article-title":"Human telomerase and its regulation","volume":"66","author":"Cong","year":"2002","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.bbrc.2004.08.135_bib4","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0959-8049(96)00521-7","article-title":"Inhibition of telomerase activity by cisplatin in human testicular cancer cells","volume":"33","author":"Burger","year":"1997","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbrc.2004.08.135_bib5","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1054\/bjoc.2000.1117","article-title":"Up-regulation of telomerase activity in human pancreatic cancer cells after exposure to etoposide","volume":"82","author":"Sato","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrc.2004.08.135_bib6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0959-8049(98)00365-7","article-title":"Cytostatic concentrations of anticancer agents do not affect telomerase activity of leukaemic cells in vitro","volume":"35","author":"Akiyama","year":"1999","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbrc.2004.08.135_bib7","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1006\/bbrc.1997.7874","article-title":"Inhibition of telomerase activity by PKC inhibitors in human nasopharyngeal cancer cells in culture","volume":"241","author":"Ku","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2004.08.135_bib8","first-page":"741","article-title":"DNA topoisomerase II as the primary cellular target for salvicine in Saccharomyces cerevisiae","volume":"21","author":"Meng","year":"2001","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbrc.2004.08.135_bib9","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0006-2952(01)00732-8","article-title":"Salvicine, a novel DNA topoisomerase II inhibitor, exerting its effects by trapping enzyme\u2013DNA cleavage complexes","volume":"62","author":"Meng","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2004.08.135_bib10","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1016\/S0960-894X(99)00472-2","article-title":"Synthesis and antitumour activity of novel diterpenequinone salvicine and the analogs","volume":"9","author":"Zhang","year":"1999","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbrc.2004.08.135_bib11","first-page":"297","article-title":"In vitro cytotoxicity of salvicine, a novel diterpenoid quinone","volume":"20","author":"Qing","year":"1999","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.bbrc.2004.08.135_bib12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/ijc.11174","article-title":"Cytotoxicity, apoptosis induction and downregulation of MDR-1 expression by the anti-topoisomerase II agent, salvicine, in multidrug-resistant tumor cells","volume":"106","author":"Miao","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrc.2004.08.135_bib13","first-page":"589","article-title":"Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay","volume":"48","author":"Alley","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2004.08.135_bib14","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/(SICI)1097-0215(20000201)85:3<330::AID-IJC6>3.0.CO;2-U","article-title":"Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium","volume":"85","author":"Ulaner","year":"2000","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrc.2004.08.135_bib15","first-page":"2007","article-title":"DNA damage transiently increases TRF2 mRNA expression and telomerase activity","volume":"17","author":"Klapper","year":"2003","journal-title":"Leukocyte"},{"key":"10.1016\/j.bbrc.2004.08.135_bib16","first-page":"579","article-title":"Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro","volume":"3","author":"Faraoni","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2004.08.135_bib17","first-page":"993","article-title":"Suppression of telomerase activity as an indicator of drug-induced cytotoxicity against cancer cells: in vitro studies with fresh human tumor samples","volume":"79","author":"Faraoni","year":"1999","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbrc.2004.08.135_bib18","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0959-8049(01)00406-3","article-title":"Decreased telomerase activity is not a reliable indicator of chemosensitivity in testicular cancer cell lines","volume":"38","author":"Cressey","year":"2002","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbrc.2004.08.135_bib19","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/S0959-8049(00)00295-1","article-title":"Attenuation of telomerase activity does not increase sensitivity of human melanoma cells to anticancer agents","volume":"36","author":"Folini","year":"2000","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbrc.2004.08.135_bib20","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0006-2952(02)01424-7","article-title":"Down-regulation of telomerase activity via protein phosphatase 2A activation in salvicine-induced human leukemia HL-60 cell apoptosis","volume":"64","author":"Liu","year":"2002","journal-title":"Biochem Pharmacol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X04019023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X04019023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T00:50:57Z","timestamp":1549241457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X04019023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0006291X04019023"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2004.08.135","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}